- Home
- ABEO vs OSUR Comparison
ABEO vs OSUR Comparison
Compare ABEO & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- OSUR
- Stock Information
- Founded
- ABEO N/A
- OSUR 2000
- Country
- ABEO United States
- OSUR United States
- Employees
- ABEO N/A
- OSUR N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- OSUR Medical/Dental Instruments
- Sector
- ABEO Health Care
- OSUR Health Care
- Exchange
- ABEO Nasdaq
- OSUR Nasdaq
- Market Cap
- ABEO 247.8M
- OSUR 289.4M
- IPO Year
- ABEO 1980
- OSUR 1986
- Fundamental
- Price
- ABEO $5.70
- OSUR $3.64
- Analyst Decision
- ABEO Strong Buy
- OSUR Hold
- Analyst Count
- ABEO 3
- OSUR 2
- Target Price
- ABEO $18.00
- OSUR $5.50
- AVG Volume (30 Days)
- ABEO 229.2K
- OSUR 1.0M
- Earning Date
- ABEO 11-14-2024
- OSUR 11-06-2024
- Dividend Yield
- ABEO N/A
- OSUR N/A
- EPS Growth
- ABEO N/A
- OSUR N/A
- EPS
- ABEO N/A
- OSUR 0.15
- Revenue
- ABEO N/A
- OSUR $224,263,000.00
- Revenue This Year
- ABEO N/A
- OSUR N/A
- Revenue Next Year
- ABEO $18,714.71
- OSUR N/A
- P/E Ratio
- ABEO N/A
- OSUR $24.10
- Revenue Growth
- ABEO 147.52
- OSUR N/A
- 52 Week Low
- ABEO $3.05
- OSUR $3.61
- 52 Week High
- ABEO $9.01
- OSUR $8.45
- Technical
- Relative Strength Index (RSI)
- ABEO 34.30
- OSUR 39.55
- Support Level
- ABEO $5.45
- OSUR $3.76
- Resistance Level
- ABEO $6.04
- OSUR $4.14
- Average True Range (ATR)
- ABEO 0.19
- OSUR 0.17
- MACD
- ABEO -0.04
- OSUR -0.01
- Stochastic Oscillator
- ABEO 19.47
- OSUR 1.02
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.